ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,131Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 198

$749K Total Retail Price of All Prescriptions

Rank: 24 out of 198

549 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,021 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 613 461 1 1
AMLODIPINE BESYLATE 493 442 2 4
OMEPRAZOLE 412 338 3 3
FUROSEMIDE 397 337 4 5
LISINOPRIL 386 307 5 6
SIMVASTATIN 360 334 6 2
HYDROCODONE-ACETAMINOPHEN 344 277 S3 7 8
POTASSIUM CHLORIDE 259 227 8 9
WARFARIN SODIUM 250 230 9 7
ATORVASTATIN CALCIUM 242 226 10 12
METOPROLOL TARTRATE 212 198 11 10
METOPROLOL SUCCINATE 209 190 12 11
CITALOPRAM HBR 204 148 13 20
ATENOLOL 191 161 14 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 167 155 15 38
GABAPENTIN 163 117 16 14
DONEPEZIL HCL 154 154 17 28
CRESTOR 148 125 18 26
PREDNISONE 147 121 19 29
SERTRALINE HCL 123 92 20 25
CARVEDILOL 120 109 21 24
HYDROCHLOROTHIAZIDE 118 106 22 16
ALLOPURINOL 112 101 23 23
PANTOPRAZOLE SODIUM 107 89 24 31
TRAMADOL HCL 107 81 24 15
SYNTHROID 107 87 24 36
MELOXICAM 107 87 24 30
FENTANYL 100 95 S2 28 73
METFORMIN HCL 98 82 29 13
NAMENDA 97 97 30 33
LANTUS 95 62 31 46
LOSARTAN POTASSIUM 95 95 31 18
ZOLPIDEM TARTRATE 92 73 33 22
FLUOXETINE HCL 90 76 34 78
QUETIAPINE FUMARATE 88 75 35 76
CLOPIDOGREL 86 86 36 42
DIOVAN 85 73 37 34
TAMSULOSIN HCL 84 84 38 27
TRIAMTERENE-HCTZ 82 81 39 32
ROPINIROLE HCL 82 51 39 74
AMITRIPTYLINE HCL 81 80 R 41 69
CIPROFLOXACIN HCL 81 67 41 55
AZITHROMYCIN 81 54 41 56
ISOSORBIDE MONONITRATE ER 75 62 44 60
FLUTICASONE PROPIONATE 73 50 45 39
MIRTAZAPINE 73 61 45 44
SPIRIVA 71 53 47 63
CYMBALTA 69 64 48 48
METFORMIN HCL ER 66 48 49 64
ENALAPRIL MALEATE 63 60 50 51
ESCITALOPRAM OXALATE 62 51 51 53
ALENDRONATE SODIUM 61 57 52 21
VENLAFAXINE HCL ER 60 53 53 84
IPRATROPIUM BROMIDE 60 60 53 134
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 57 53 90
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 56 49
PRAVASTATIN SODIUM 59 50 56 19
PLAVIX 58 58 58 66
SPIRONOLACTONE 57 54 59 37
PAROXETINE HCL 56 47 60 65
PROPRANOLOL HCL 55 55 61 92
ZOSTAVAX 55 47 61 169
EXELON 54 54 63 123
RISPERIDONE 52 52 64 82
VESICARE 51 51 65 77
TRAZODONE HCL 50 32 66 50
AMLODIPINE BESYLATE-BENAZEPRIL 50 44 66 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.